Stock ANTX AN2 THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features AN2 Therapeutics, Inc.

Equities

ANTX

US0373261058

Real-time Estimate Cboe BZX
Other stock markets
 11:41:52 2024-06-10 am EDT 		5-day change 1st Jan Change
1.985 USD -2.22% Intraday chart for AN2 Therapeutics, Inc. -5.24% -90.29%
May. 16 Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating MT
May. 14 AN2 Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANTX Stock
  4. News AN2 Therapeutics, Inc.
  5. MarketScreener Editorial Features